9-Nitrocamptothecin as second line chemotherapy for men with progressive, metastatic, hormone refractory prostate cancer: Results of the CALGB 99901

Amin, Asim, Halabi, Susan, Gelmann, Edward P. · Urologic Oncology: Seminars and Original Investigations · 2004